Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuous versus intermittent intravenous furosemide in neonates with heart failure
IRCT20210317050737N1Phase 2Completed
- Sponsor
- Kerman University of Medical Sciences
- Start
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of furosemide in heart failure (HF), sponsored by Kerman University of Medical Sciences. Started Jan 2023; status: completed.
02
Drugs
furosemide
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on IRCT20210317050737N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210317050737N1.